SCNLF (Scancell Holdings) Total Stockholders Equity: $-11.18 Mil (As of Oct. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SCNLF Scancell Holdings PLC SCNLF
16 GF Score
Price $0.13
! 1 Warning Sign
View Full Analysis

What is Scancell Holdings Total Stockholders Equity?

Scancell Holdings SCNLF 16 Total Stockholders Equity is $-11.18 Mil as of Oct. 2025. GuruFocus rates SCNLF with a GF Score™ of 16/100. The stock has 1 warning sign investors should review.

Scancell Holdings's Total Stockholders Equity for the quarter that ended in Oct. 2025 was $-11.18 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Scancell Holdings's Book Value per Share for the quarter that ended in Oct. 2025 was $-0.01. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Scancell Holdings's Debt-to-Equity for the quarter that ended in Oct. 2025 was -1.93.


Scancell Holdings  (OTCPK:SCNLF) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Scancell Holdings's Book Value per Share for the quarter that ended in Oct. 2025 is

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Scancell Holdings's Debt-to-Equity for the quarter that ended in Oct. 2025 is

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Scancell Holdings Total Stockholders Equity Related Terms


Scancell Holdings Total Stockholders Equity Historical Data

* Premium members only.

The historical data trend for Scancell Holdings's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Scancell Holdings Total Stockholders Equity Chart

Scancell Holdings Annual Data
Trend Apr16 Apr17 Apr18 Apr19 Apr20 Apr21 Apr22 Apr23 Apr24 Apr25
Total Stockholders Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 12.03 1.80 -12.02 -4.39 -5.04

Scancell Holdings Semi-Annual Data
Apr16 Oct16 Apr17 Oct17 Apr18 Oct18 Apr19 Oct19 Apr20 Oct20 Apr21 Oct21 Apr22 Oct22 Apr23 Oct23 Apr24 Oct24 Apr25 Oct25
Total Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -10.19 -4.39 -20.21 -5.04 -11.18
SCNLF
16GF Score
Scancell Holdings PLC SCNLF
Total Stockholders Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a Total Stockholders Equity of $-11.18 Mil mean?
Scancell Holdings (SCNLF) has a Total Stockholders Equity of $-11.18 Mil as of Oct. 2025. The total amount of shareholder's equity as recorded on a company's balance sheet. View historical data for Scancell Holdings and its competitors.
Is Scancell Holdings' Total Stockholders Equity too high?
Scancell Holdings' current Total Stockholders Equity is $-11.18 Mil. Overall, Scancell Holdings has a GF Score™ of 16/100, reflecting its overall financial health beyond just this single metric.
How does Scancell Holdings' Total Stockholders Equity compare to VRTX and REGN?
Scancell Holdings' Total Stockholders Equity of $-11.18 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Stockholders Equity for a Biotechnology company?
A good Total Stockholders Equity depends on the Biotechnology industry context. However, Total Stockholders Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Stockholders Equity mean?
A high Total Stockholders Equity can signal that a stock is expensive relative to its fundamentals. The total amount of shareholder's equity as recorded on a company's balance sheet. View historical data for Scancell Holdings and its competitors. Scancell Holdings's current Total Stockholders Equity is $-11.18 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Scancell Holdings stock overvalued right now?
Scancell Holdings (SCNLF) has a current Total Stockholders Equity of $-11.18 Mil. The current Total Stockholders Equity is $-11.18 Mil. Scancell Holdings' overall GF Score™ is 16/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Stockholders Equity calculated?
Total Stockholders Equity is calculated from a company's financial statements. For Scancell Holdings (SCNLF), the current Total Stockholders Equity is $-11.18 Mil as of Oct. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Scancell Holdings Business Description

Other Exchanges SCLP:UKSCP:Germany
Address Sanders Road, Unit 202, Bellhouse Building, Oxford Science Park, Oxford, GBR, OX4 4GD
Scancell Holdings PLC is a clinical-stage biotechnology company developing targeted off-the-shelf active immunotherapies to generate safe and long-lasting tumour-specific immunity for a cancer-free future. iSCIB1+, a product from its DNA ImmunoBody platform (AvidiMab), has demonstrated safe, durable, and clinically meaningful benefit as a monotherapy as well as additional benefit when combined with checkpoint therapies in an ongoing Phase 2 trial in melanoma. Modi-1, the peptide immunotherapy from its Moditope platform, is being investigated in a Phase 2 study in a broad range of solid tumours. In addition, the company has established a subsidiary with the intention to hold and develop an early-stage pipeline of high-affinity GlyMab antibodies targeting tumour-specific glycans.
16GF Score

Get the complete analysis for SCNLF

Total Stockholders Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.13
Price